Logotipo do repositório
 

Publicação:
Modulation of eosinophil generation and migration by Mangifera indica L. extract (Vimang (R))

dc.contributor.authorSa-Nunes, Anderson
dc.contributor.authorRogerio, Alexandre P.
dc.contributor.authorMedeiros, Alexandra Ivo de [UNESP]
dc.contributor.authorFabris, Viciany E.
dc.contributor.authorAndreu, Gilberto P.
dc.contributor.authorRivera, Dagmar G.
dc.contributor.authorDelgado, Ren
dc.contributor.authorFaccioli, Lucia H.
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionCtr Quim Farmaceut
dc.date.accessioned2014-05-20T15:21:04Z
dc.date.available2014-05-20T15:21:04Z
dc.date.issued2006-09-01
dc.description.abstractThe effects of Vimang((R)), an aqueous extract of the stem bark of Mangifera indica L. (Anacardiaccae), on cell migration in an experimental model of asthma was investigated. In vivo treatment of Toxocara canis-infected BALB/c mice for 18 days with 50 mg/kg Vimang((R)) reduced eosinophil migration into the bronchoalveolar space and peritoneal cavity. Also, eosinophil generation in bone marrow and blood eosinophilia were inhibited in infected mice treated with Vimang((R)). This reduction was associated with inhibition of IL-5 production in serum and eotaxin in lung homogenates. In all these cases the effects of Vimang((R)) were more selective than those observed with dexamethasone. Moreover, Virnang((R)) treatment is not toxic for the animals, as demonstrated by the normal body weight increase during infection. These data confirm the potent anti-inflammatory effect of Vimang R and support its potential use as an alternative therapeutic drug to the treatment of eosinophilic disorders including those caused by nematodes and allergic diseases. (c) 2006 Elsevier B.V. All rights reserved.en
dc.description.affiliationUniv São Paulo, Fac Ciências Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14040903 Ribeirao Preto, Brazil
dc.description.affiliationUniv Estadual Paulista, Fac Med, BR-18618917 Botucatu, SP, Brazil
dc.description.affiliationCtr Quim Farmaceut, Dept Invest Biomed, Havana, Cuba
dc.description.affiliationUnespUniv Estadual Paulista, Fac Med, BR-18618917 Botucatu, SP, Brazil
dc.format.extent1515-1523
dc.identifierhttp://dx.doi.org/10.1016/j.intimp.2006.04.008
dc.identifier.citationInternational Immunopharmacology. Amsterdam: Elsevier B.V., v. 6, n. 9, p. 1515-1523, 2006.
dc.identifier.doi10.1016/j.intimp.2006.04.008
dc.identifier.issn1567-5769
dc.identifier.urihttp://hdl.handle.net/11449/32245
dc.identifier.wosWOS:000239674000016
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofInternational Immunopharmacology
dc.relation.ispartofjcr3.118
dc.relation.ispartofsjr1,051
dc.rights.accessRightsAcesso restritopt
dc.sourceWeb of Science
dc.subjectanti-inflammatory activitypt
dc.subjecteosinophilspt
dc.subjectToxocara canispt
dc.subjectMangifera indicapt
dc.subjectdexamethasonept
dc.titleModulation of eosinophil generation and migration by Mangifera indica L. extract (Vimang (R))en
dc.typeArtigopt
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
dspace.entity.typePublication
relation.isDepartmentOfPublication5004bcab-94af-4939-b980-091ae9d0a19e
relation.isDepartmentOfPublication.latestForDiscovery5004bcab-94af-4939-b980-091ae9d0a19e
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.author.lattes8756770929017974[3]
unesp.author.orcid0000-0002-1859-4973[1]
unesp.author.orcid0000-0001-5913-3703[2]
unesp.author.orcid0000-0002-4999-8305[8]
unesp.author.orcid0000-0001-6048-3647[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentCiências Biológicas - FCFpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: